Recently, the molecular landscape of a cohort including MDS patients with AID was reported with a higher frequency of mutations in the TET2, IDH1/2 and SRSF2 genes compared to a cohort of 319 MDS patients without AID [32]. The gene discussed is TET2; the disease is myelodysplastic syndrome.